Xponance Inc. Has $2.39 Million Position in Avantor, Inc. (NYSE:AVTR)

Xponance Inc. increased its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 5.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 113,456 shares of the company’s stock after buying an additional 6,310 shares during the period. Xponance Inc.’s holdings in Avantor were worth $2,391,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB grew its position in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after buying an additional 625 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after acquiring an additional 830 shares during the period. Global Retirement Partners LLC boosted its holdings in Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after acquiring an additional 1,067 shares during the last quarter. UMB Bank n.a. increased its position in Avantor by 56.3% during the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after purchasing an additional 1,074 shares during the period. Finally, AlphaQuest LLC bought a new position in Avantor during the 4th quarter worth approximately $65,000. 95.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of analyst reports. Wells Fargo & Company reduced their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. UBS Group reiterated a “neutral” rating and set a $25.00 price target (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Citigroup lowered their price objective on Avantor from $22.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Morgan Stanley decreased their target price on Avantor from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Finally, Barclays dropped their price target on Avantor from $26.00 to $23.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $25.50.

Avantor Price Performance

Shares of NYSE:AVTR opened at $16.61 on Friday. Avantor, Inc. has a twelve month low of $15.37 and a twelve month high of $28.00. The stock’s 50 day moving average is $18.98 and its 200-day moving average is $21.74. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $11.31 billion, a price-to-earnings ratio of 15.97, a PEG ratio of 1.55 and a beta of 1.30.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the previous year, the company earned $0.22 earnings per share. Sell-side analysts forecast that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Insider Buying and Selling at Avantor

In other news, EVP James Bramwell sold 3,758 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the sale, the executive vice president now directly owns 87,379 shares of the company’s stock, valued at $1,531,753.87. This trade represents a 4.12 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. This trade represents a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.30% of the company’s stock.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.